Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2016, Article ID 1821230, 4 pages
http://dx.doi.org/10.1155/2016/1821230
Case Report

A Case of Thanatophoric Dysplasia Type I with Fetal Hydrops in the First Trimester

1Department of Obstetrics and Gynecology, Meiwa General Hospital, Nishinomiya 663-8186, Japan
2Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan

Received 6 January 2016; Revised 26 January 2016; Accepted 26 January 2016

Academic Editor: Giovanni Monni

Copyright © 2016 Giannina Calongos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Sawai, S. Komori, A. Ida, T. Henmi, T. Bessho, and K. Koyama, “Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results,” Prenatal Diagnosis, vol. 19, no. 1, pp. 21–24, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Maroteaux, M. Lamy, and J. M. Robbert, “Le nanisme thanatophore,” La Presse Médicale, vol. 49, pp. 2519–2524, 1967. View at Google Scholar
  3. B. Karczeski and G. R. Cutting, “Thanatophoric dysplasia,” in GeneReviews, NCBI Bookshelf, 2013. View at Google Scholar
  4. G. Nishimura, J. Murotsuki, and H. Sawai, “Fetal diagnosis and perinatal management of skeletal dysplasias. Medical View,” Sawai H. Fetal diagnosis and perinatal management of skeletal dysplasias. Medical View, p. 122, 2011. View at Google Scholar
  5. S. M. Nikkel, N. Major, and W. J. King, “Growth and development in thanatophoric dysplasia—an update 25 years later,” Clinical Case Reports, vol. 1, no. 2, pp. 75–78, 2013. View at Publisher · View at Google Scholar
  6. K. Amano and Y. Ushibashi, Compact Atlas of Obstetrics and Gynecology Ultrasound, Vector Core, 2012.
  7. W. Yeom, E. S. Paik, J.-J. An et al., “Clinical characteristics and perinatal outcome of fetal hydrops,” Obstetrics & Gynecology Science, vol. 58, no. 2, pp. 90–97, 2015. View at Publisher · View at Google Scholar
  8. M. E. Abrams, K. S. Meredith, P. Kinnard, and R. H. Clark, “Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death,” Pediatrics, vol. 120, no. 1, pp. 84–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Khalil, E. Pajkrt, and L. S. Chitty, “Early prenatal diagnosis of skeletal anomalies,” Prenatal Diagnosis, vol. 31, no. 1, pp. 115–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. S. Chitty, A. Khalil, A. N. Barrett, E. Pajkrt, D. R. Griffin, and T. J. Cole, “Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA,” Prenatal Diagnosis, vol. 33, no. 5, pp. 416–423, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Rahemtullah, B. McGillivray, and R. D. Wilson, “Suspected skeletal dysplasias: femur length to abdominal circumference ratio can be used in ultrasonographic prediction of fetal outcome,” American Journal of Obstetrics and Gynecology, vol. 177, no. 4, pp. 864–869, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Johnson, N. A. Callan, and V. K. Bhutani, “Ultrasonic ratio of fetal thoracic to abdominal circumference: an association with fetal pulmonary hypoplasia,” American Journal of Obstetrics & Gynecology, vol. 157, no. 3, pp. 764–769, 1987. View at Publisher · View at Google Scholar · View at Scopus
  13. P. L. Tavormina, R. Shiang, L. M. Thompson et al., “Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3,” Nature Genetics, vol. 9, no. 3, pp. 321–328, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Legeai-Mallet, C. Benoist-Lasselin, A.-L. Delezoide, A. Munnich, and J. Bonaventure, “Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia,” The Journal of Biological Chemistry, vol. 273, no. 21, pp. 13007–13014, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Yamada, H. Sawai, G. Nishimura, H. Numabe, K. Cho, and H. Minakami, “Platyspondylic lethal skeletal dysplasia San Diego type (thanatophoric dysplasia type 1) associated with trisomy 21 presenting with nuchal translucency: a case report,” Prenatal Diagnosis, vol. 29, no. 7, pp. 715–717, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. S. Naveen, B. V. Murlimanju, V. Kumar, T. Pulakunta, and H. Jeeyar, “Thanatophoric dysplasia: a rare entity,” Oman Medical Journal, vol. 26, no. 3, pp. 196–197, 2011. View at Publisher · View at Google Scholar · View at Scopus